PO Box 83395

Gaithersburg, MD 20883




(301) 525-2321


  • White LinkedIn Icon


August 15, 2018

This week, the FDA approved Alnylam Pharmaceuticals’ ONPATTRO™ (patisiran), an innovative RNA interference (RNAi) therapy to treat polyneuropathy of hATTR amyloidosis. As you may imagine, this advanced, Nobel Prize-winning technology comes at a premium price, over $400...

July 24, 2018

Skeptics of bundled payments, even if they are not proponents of line-item payments, scored a victory last week with the publication of a study in the New England Journal of Medicine that determined no significant difference in costs or outcomes in a Medicare bundled p...

February 23, 2018

The first or second question anyone asks during a social event, or on the sidelines of a middle school soccer game, is what I do for a living. After I give my well-rehearsed elevator speech of the importance of drug or device reimbursement, the person speaking with me...

September 11, 2017

Let's discuss payers reimbursing for digital health applications

Please reload